Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
Abstract Background B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor (CAR)-T-cell therapy is an emerging treatment option for multiple myeloma. The aim of this systematic review and meta-analysis was to determine its safety and clinical activity and to identify factors influencing...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2020-12-01
|
| Colección: | Journal of Hematology & Oncology |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s13045-020-01001-1 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|